Consilium Wealth Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Consilium Wealth Advisory's LLY Position: Q3 2026 in Review
Consilium Wealth Advisory increased its Eli Lilly (LLY) stake by 3.1% in Q3 2026, buying an estimated $135K and bringing the position to 3,827 shares worth $4.43M. The position accounts for 1.31% of the portfolio, ranked #21.
Consilium Wealth Advisory first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $4.45M in Q2 2026. 2,535 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Consilium Wealth Advisory held 3,827 shares of Eli Lilly worth $4.43M as of Q3 2026.
- Consilium Wealth Advisory bought 114 Eli Lilly shares in Q3 2026, an estimated $135K.
- Eli Lilly made up 1.31% of Consilium Wealth Advisory's portfolio in Q3 2026, its #21 holding.
- Consilium Wealth Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- Consilium Wealth Advisory's Eli Lilly position peaked at $4.45M in Q2 2026.
- 2,535 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Consilium Wealth Advisory's 13F filing for Q3 2026, filed 14 Oct 2026.